Raia Drogasil S.A. (OTCMKTS:RADLY – Get Free Report) shares saw unusually-high trading volume on Thursday . Approximately 266,419 shares traded hands during mid-day trading, an increase of 1,451% from the previous session’s volume of 17,175 shares.The stock last traded at $3.87 and had previously closed at $3.70.
Wall Street Analysts Forecast Growth
Separately, Zacks Research upgraded shares of Raia Drogasil to a “hold” rating in a report on Thursday, April 9th. One equities research analyst has rated the stock with a Hold rating, Based on data from MarketBeat, Raia Drogasil has an average rating of “Hold”.
Get Our Latest Stock Report on Raia Drogasil
Raia Drogasil Stock Up 4.6%
Raia Drogasil Company Profile
Raia Drogasil SA is a leading Brazilian retail pharmacy operator, offering a comprehensive range of prescription and over-the-counter medications, health and wellness products, personal care and beauty items, as well as a selection of convenience goods. The company’s network of stores operates under the Raia and Drogasil banners, serving diverse consumer needs across major urban centers. Complementary services include in-store prescription dispensing, compounding pharmacies and health screening programs such as blood pressure and glucose monitoring.
The company was formed in 2011 through the merger of two established Brazilian pharmacy chains, Drogasil and Droga Raia, each with origins dating back several decades.
Featured Stories
- Five stocks we like better than Raia Drogasil
- Snowflake and the Snowballing Impact of its AI Flywheel
- AI’s Biggest Bottleneck Could Make These 2 Stocks Soar
- These 3 Beaten-Down Stocks Just Saw $25 Million in Insider Buying
- IREN Is Flipping the Switch from Bitcoin to AI
Receive News & Ratings for Raia Drogasil Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Raia Drogasil and related companies with MarketBeat.com's FREE daily email newsletter.
